Stressor-Like Effects of c-Jun N-Terminal Kinase (JNK) Inhibition

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Clarke, Melanie ^a   Pentz, Rowan ^a   Bobyn, Jessica ^a   Hayley, Shawn ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; NORADRENALIN; PLACEBO; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ACUTE STRESS; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; EXPLORATORY BEHAVIOR; HORMONE ACTION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IN VITRO STUDY; LOCUS CERULEUS; MAZE TEST; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; OPEN FIELD TEST; PROTEIN PROTEIN INTERACTION;

AMYGDALA; ANIMALS; ANTHRACENES; BLOTTING, WESTERN; CORTICOSTERONE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAZE LEARNING; MICE; NOREPINEPHRINE; PROTEIN KINASE INHIBITORS; STRESS, PHYSIOLOGICAL;

MUS;

EID: 84865611093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044073     Document Type: Article

References (51)

1. Frodl T, O'Keane V (2012) How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol Dis [In Press].
2. Hayley S, Poulter MO, Merali Z, Anisman H, (2005) The pathogenesis of clinical depression: stressor - and cytokine-induced alterations of neuroplasticity. Neuroscience 135: 659-678.
3. Pittenger C, Duman RS, (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33: 88-109.
4. McEwen BS, Eiland L, Hunter RG, Miller MM, (2012) Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 62: 3-12.
5. Anisman H, (2009) Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 34: 4-20.
6. Harvey BH, Brand L, Jeeva Z, Stein DJ, (2006) Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder. Physiol Behav 87: 881-890.
7. Choi DC, Furay AR, Evanson NK, Ulrich-Lai YM, Nguyen MM, et al. (2008) The role of the posterior medial bed nucleus of the stria terminalis in modulating hypothalamic-pituitary adrenocortical axis responsiveness to acute and chronic stress. Psychoneuroendocrinology 33: 659-669.
8. Ma S, Mifflin SW, Cunningham JT, Morilak DA, (2008) Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress. Neuroscience 154: 1639-1647.
9. Roy V, Merali Z, Poulter MO, Anisman H, (2007) Anxiety responses, plasma corticosterone and central monoamine variations elicited by stressors in reactive and nonreactive mice and their reciprocal F1 hybrids. Behav Brain Res 185: 49-58.
10. McEwen BS, (2000) Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22: 108-124.
11. Galliher-Beckley AJ, Cidlowski JA, (2009) Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life 61: 979-86.
12. Davies L, Karthikeyan N, Lynch JT, Sial EA, Gkourtsa A, et al. (2008) Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function. Mol Endocrinol 22: 1331-1344.
13. Wang X, Wu H, Lakdawala VS, Hu F, Hanson ND, et al. (2005) Inhibition of Jun N-terminal kinase (JNK) enhances glucocorticoid receptor-mediated function in mouse hippocampal HT22 cells. Neuropsychopharmacology 30: 242-249.
14. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, et al. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15: 2760-2770.
15. Karin M, (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486.
16. Davis RJ, (1994) MAPKs: new JNK expands the group. Trends Biochem Sci 19: 470-473.
17. Meller E, Changpeng S, Nikolao T, Jensen C, Tsimberg Y, et al. (2003) Region-specific effects of acute and repeated restraint stress on the phosphorylation of mitogen-activated protein kinases. Brain Res 979: 57-64.
18. Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, et al. (2011) Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron. 71(3): 498-511.
19. Bland ST, Schmid MJ, Greenwood BN, Watkins LR, Maier SF, (2006) Behavioral control of the stressor modulates stress-induced changes in neurogenesis and fibroblast growth factor-2. Neuroreport 17: 593-597.
20. Duman RS, Nakagawa S, Malberg J, (2001) Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25: 836-844.
21. Karten YJ, Nair SM, van Essen L, Sibug R, Joëls M, (1999) Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons. Proc Natl Acad Sci U S A 96: 13456-13461.
22. Sapolsky RM, Uno H, Rebert CS, Finch CE, (1990) Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10: 2897-2902.
23. Weston C. Davis R, (2007) The JNK signal transduction pathway. Curr Opinn Cell Biol 19: 142-149.
24. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, et al. (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem 76: 435-441.
25. Colombo A, Repici M, Pesaresi M, Santambrogio S, Forloni G, et al. (2007) The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability. Cell Death Differ 14: 1845-1848.
26. Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, et al. (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 101: 665-670.
27. Guan QH, Pei DS, Zong YY, Xu TL, Zhang GY, (2006) Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways. Neuroscience 139: 609-627.
28. Li XM, Li CC, Yu SS, Chen JT, Sabapathy K, et al. (2007) JNK1 contributes to metabotropic glutamate receptor-dependent long-term depression and short-term synaptic plasticity in the mice area hippocampal CA1. Eur J Neurosci 25: 391-396.
29. Curran BP, Murray HJ, O'Connor JJ, (2003) Role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro. Neuroscience 118: 347-357.
30. Waetzig V, Zhao Y, Herdegen T, (2006) The bright side of JNKs: multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog Neurobiol 80: 84-97.
31. Adzic M, Djordjevic J, Djordjevic A, Niciforovic A, Demonacos C, et al. (2009) Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J Endocrinol 202: 87-97.
32. Karin M, (1998) Mitogen-Activated Protein Kinase Cascades as Regulators of Stress Responses. Ann N Y Acad Sci 851: 139-146.
33. Haeusgen W, Boehm R, Zhao Y, Herdegen T, Waetzig V, (2009) Specific activities of individual c-Jun N-terminal kinases in the brain. Neuroscience 161: 951-959.
34. Bruna A, Nicolas M, Munoz A, Kyriakis JM, Caelles C, (2003) Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 22: 6035-6044.
35. Budziszewska B, Szymanska M, Leskiewicz M, Basta-Kaim A, Jaworska-Feil L, et al. (2010) The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. J Physiol Pharmacol 61: 207-215.
36. Li H, Zhang L, Huang Q, (2009) Differential expression of mitogen-activated protein kinase signaling pathway in the hippocampus of rats exposed to chronic unpredictable stress. Behav Brain Res 205: 32-37.
37. Bevilaqua LRM, Kerr DS, Medina JH, Izquierdo I, Cammarota M, (2003) Inhibition of hippocampal Jun N-terminal kinase enhances short-term memory but blocks long-term memory formation and retrieval of an inhibitory avoidance task. Eur J Neurosci 17: 897-902.
38. Wang W, Shi L, Xie Y, Ma C, Li W, et al. (2004) SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease. Neurosci Res 48: 195-202.
39. Yatsushige H, Ostrowski RP, Tsubokawa T, Colohan A, Zang JH, (2007) Role of c-Jun N-Terminal Kinase in Early Brain Injury After Subarachnoid Hemorrhage. J Neurosci Res 85: 1436-1448.
40. Mehan S, Meena H, Sharma D, Sankhla R, (2011) JNK: A Stress-Activated Protein Kinase Therapeutic Strategies and Involvement in Alzheimer's and Various Neurodegenerative Abnormalities. J Mol Neurosci 43: 376-390.
41. Unger EK, Piper ML, Olofsson LE, Xu AW, (2010) Functional Role of c-Jun N-Terminal Kinase in Feeding Regulation. Endocrinology 151: 671-682.
42. Watanabe G, Pena P, Albanese C, Wilsbacher LD, Young JB, et al. (1997) Adrenocorticotropin induction of stress-activated protein kinase in the adrenal cortex in vivo. J Biol Chem 272: 20063-20069.
43. Yoshimura K, Ueno M, Lee S, Nakamura Y, Sato A, et al. (2011) C-Jun N-terminal kinase induces axonal degeneration and limits motor recovery after spinal cord injury in mice. Neurosci Research 71: 266-277.
44. de Oliveira AC, Candelario-Jalil E, Bhatia HS, Lieb K, Hüll M, et al. (2008) Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. Glia. 56(8): 844-55.
45. Johnson RW, Curtis SE, Dantzer R, Kelley KW, (1993) Central and peripheral prostaglandins are involved in sickness behavior in birds. Physiol Behav. 1993 53(1): 127-31.
46. Niimi K, Nishioka C, Miyamoto T, Takahashi E, Miyoshi I, et al. (2011) Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice. Biochem Biophys Res Commun 406(4): 524-528.
47. Szumlinski KK, Haskew RE, Balogun MY, Maisonneuve IM, Glick SD, (2001) Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties. Pharmacol Biochem Behav 69(3-4): 485-491.
48. Feldman S, Conforti N, Itzik A, Weidenfeld J, (1994) Differential effect of amygdaloid lesions on CRF-41, ACTH and CORT responses following neural stimuli. Brain Res 658: 21-26.
49. Tanaka M, Tsuda A, Kohno Y, Hoaki Y, Nagasaki N, (1983) Regional Rat brain Noradrenaline Turnover in Response to Restraint Stress. Pharmacol Biochem Behav 19: 287-290.
50. Chan-Palay V, (1993) Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy. Adv Neurol 60: 438-446.
51. Abercrombie ED, Jacobs BL, (1988) Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not nonstressful conditions. Brain Res 441: 362-366.